Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: A pooled analysis of the EXAMINATION (clinical evaluation of the xience-V stent in acute myocardial INfArcTION) and COMFORTABLE-AMI

JACC: Cardiovascular Interventions

Volumn 7, Issue 1, 2014, Pages 55-63

  Sabaté, Manel ^a   Räber, Lorenz ^b   Heg, Dik ^c   Brugaletta, Salvatore ^a   Kelbaek, Henning ^d   Cequier, Angel ^e   Ostojic, Miodrag ^f   Iñiguez, Andrés ^g   Tüller, David ^h   Serra, Antonio ⁱ   Baumbach, Andreas ^j   Von Birgelen, Clemens ^k   Hernandez Antolin, Rosana ^l   Roffi, Marco ^m   Mainar, Vicente ⁿ   Valgimigli, Marco ^o   Serruys, Patrick W ^p   Jüni, Peter ^c   Windecker, Stephan ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d Rigshospitalet   (Denmark)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f CLINICAL CENTER OF SERBIA   (Serbia)

^g HOSPITAL DO MEIXOEIRO   (Spain)

^h TRIEMLI HOSPITAL   (Switzerland)

ⁱ HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^j UNIVERSITY OF BRISTOL   (United Kingdom)

^k UNIVERSITY OF TWENTE   (Netherlands)

^l HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^m REGIONAL HOSPITAL OF LUGANO   (Switzerland)

ⁿ HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^o UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^p ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

drug eluting stent(s); STEMI; stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; PRASUGREL; UMIROLIMUS;

ADULT; ARTICLE; BARE METAL STENT; CARDIOVASCULAR MORTALITY; CLINICAL EVALUATION; COMPARATIVE STUDY; DRUG ELUTING STENT; FEMALE; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; REVASCULARIZATION; SAFETY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; BIOSENSOR; CAUSE OF DEATH; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; LONG TERM CARE; MULTICENTER STUDY; PATIENT CODING; RANDOMIZED CONTROLLED TRIAL; STENT THROMBOSIS;

BARE-METAL STENT(S); BES; BIOLIMUS A9-ELUTING STENT(S); BMS; CI; CONFIDENCE INTERVAL; DES; DEVICE-ORIENTED COMPOSITE ENDPOINT; DOCE; DRUG-ELUTING STENT(S); EES; EVEROLIMUS-ELUTING STENT(S); HAZARD RATIO; HR; PATIENT-ORIENTED COMPOSITE ENDPOINT; POCE; RELATIVE RISK; RR; ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEMI; STENT THROMBOSIS;

AGED; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893663171     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.07.012     Document Type: Article

References (35)

1. G.W. Stone, A.J. Lansky, and S.J. Pocock et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
2. C. Spaulding, P. Henry, and E. Teiger et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction N Engl J Med 355 2006 1093 1104 (Pubitemid 44394916)
3. G.J. Laarman, M.J. Suttorp, and M.T. Dirksen et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention N Engl J Med 355 2006 1105 1113 (Pubitemid 44394917)
4. M. Menichelli, A. Parma, and E. Pucci et al. Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI) J Am Coll Cardiol 49 2007 1924 1930 (Pubitemid 46694284)
5. M. Valgimigli, G. Percoco, and P. Malagutti et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial JAMA 293 2005 2109 2117 (Pubitemid 40617063)
6. M. Valgimigli, G. Campo, and G. Percoco et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial JAMA 299 2008 1788 1799 (Pubitemid 351549970)
7. G. Nakazawa, A.V. Finn, and M. Joner et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study Circulation 118 2008 1138 1145
8. N. Gonzalo, P. Barlis, and P.W. Serruys et al. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography J Am Coll Cardiol Intv 2 2009 445 452
9. L. Raber, and S. Windecker Current status of drug-eluting stents Cardiovasc Ther 29 2011 176 189
10. L. Raber, H. Kelbaek, and M. Ostojic et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial JAMA 308 2012 777 787
11. M. Sabate, A. Cequier, and A. Iniguez et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 380 2012 1482 1490
12. M. Sabate, A. Cequier, and A. Iniguez et al. Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction EuroIntervention 7 2011 977 984
13. L. Raber, H. Kelbaek, and M. Ostoijc et al. Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design EuroIntervention 7 2012 1435 1443
14. P. Vranckx, D.E. Cutlip, and R. Mehran et al. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies EuroIntervention 5 2010 871 874
15. D.E. Cutlip, S. Windecker, and R. Mehran et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
16. M.C. Morice, P.W. Serruys, and J.E. Sousa et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780 (Pubitemid 34586912)
17. J.W. Moses, M.B. Leon, and J.J. Popma et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
18. H.K. Win, A.E. Caldera, and K. Maresh et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents JAMA 297 2007 2001 2009 (Pubitemid 46740352)
19. O.C. Marroquin, F. Selzer, and S.R. Mulukutla et al. A comparison of bare-metal and drug-eluting stents for off-label indications N Engl J Med 358 2008 342 352 (Pubitemid 351159233)
20. I. Iakovou, T. Schmidt, and E. Bonizzoni et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)
21. A. Kastrati, J. Mehilli, and J. Pache et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039 (Pubitemid 46376803)
22. P. Wenaweser, J. Daemen, and M. Zwahlen et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
23. N. Beohar, C.J. Davidson, and K.E. Kip et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents JAMA 297 2007 1992 2000 (Pubitemid 46740351)
24. A.V. Finn, G. Nakazawa, and M. Joner et al. Vascular responses to drug eluting stents: importance of delayed healing Arterioscler Thromb Vasc Biol 27 2007 1500 1510 (Pubitemid 46986103)
25. M. Joner, A.V. Finn, and A. Farb et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
26. S. Brugaletta, M. Sabate, and V. Martin-Yuste et al. Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: insights from the EXAMINATION trial Int J Cardiol 168 2013 2632 2636
27. K. Kolandaivelu, R. Swaminathan, and W.J. Gibson et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings Circulation 123 2011 1400 1409
28. G. Sianos, M.I. Papafaklis, and J. Daemen et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden J Am Coll Cardiol 50 2007 573 583 (Pubitemid 47198999)
29. G. Davi, and C. Patrono Platelet activation and atherothrombosis N Engl J Med 357 2007 2482 2494
30. R. Virmani, A.P. Burke, A. Farb, and F.D. Kolodgie Pathology of the vulnerable plaque J Am Coll Cardiol 47 2006 C13 C18
31. T. Palmerini, G. Biondi-Zoccai, and D. Della Riva et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
32. T. Palmerini, A.J. Kirtane, and P.W. Serruys et al. Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials Circulation Cardiovasc Interv 5 2012 357 364
33. G.G. Stefanini, R.A. Byrne, and P.W. Serruys et al. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials Eur Heart J 33 2012 1214 1222
34. E. Camenzind, W. Wijns, and L. Mauri et al. Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial Lancet 380 2012 1396 1405
35. B. Kalesan, T. Pilgrim, and K. Heinimann et al. Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction Eur Heart J 33 2012 977-7